These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30962400)

  • 1. Transmission-Blocking Vaccines: Old Friends and New Prospects.
    Acquah FK; Adjah J; Williamson KC; Amoah LE
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
    Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
    de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
    Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally acquired immunity to sexual stage P. falciparum parasites.
    Stone WJ; Dantzler KW; Nilsson SK; Drakeley CJ; Marti M; Bousema T; Rijpma SR
    Parasitology; 2016 Feb; 143(2):187-98. PubMed ID: 26743529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural vaccinology of malaria transmission-blocking vaccines.
    Patel PN; Tolia N
    Expert Rev Vaccines; 2021 Feb; 20(2):199-214. PubMed ID: 33430656
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.
    Theisen M; Jore MM; Sauerwein R
    Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in
    Chan JA; Drew DR; Reiling L; Lisboa-Pinto A; Dinko B; Sutherland CJ; Dent AE; Chelimo K; Kazura JW; Boyle MJ; Beeson JG
    Front Immunol; 2018; 9():3126. PubMed ID: 30692996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.
    Duffy PE
    Expert Rev Vaccines; 2021 Feb; 20(2):185-198. PubMed ID: 33478283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.
    Arévalo-Herrera M; Solarte Y; Marin C; Santos M; Castellanos J; Beier JC; Valencia SH
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1(Suppl 1):202-11. PubMed ID: 21881775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.
    Lavazec C; Boudin C; Lacroix R; Bonnet S; Diop A; Thiberge S; Boisson B; Tahar R; Bourgouin C
    Infect Immun; 2007 Apr; 75(4):1635-42. PubMed ID: 17283100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous Expression and Evaluation of Novel
    de Jong RM; Singh SK; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Stone WJR; Locke E; Plieskatt J; Theisen M; Bousema T; Jore MM
    Front Immunol; 2022; 13():909060. PubMed ID: 35812379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Characterization and Comparison of
    Nikolaeva D; Illingworth JJ; Miura K; Alanine DGW; Brian IJ; Li Y; Fyfe AJ; Da DF; Cohuet A; Long CA; Draper SJ; Biswas S
    Mol Cell Proteomics; 2020 Jan; 19(1):155-166. PubMed ID: 29089373
    [No Abstract]   [Full Text] [Related]  

  • 17. Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate.
    Williamson KC; Fujioka H; Aikawa M; Kaslow DC
    Mol Biochem Parasitol; 1996 Jun; 78(1-2):161-9. PubMed ID: 8813686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of transmission success of Plasmodium falciparum gametocytes (sexual stages) in various species of Anopheles by erythrocytic asexual stage parasites.
    Kumar N
    Acta Trop; 2017 Dec; 176():263-269. PubMed ID: 28859956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exposure to mosquito transmission-blocking antibodies on Plasmodium falciparum population genetic structure.
    Sandeu MM; Abate L; Tchioffo MT; Bayibéki AN; Awono-Ambéné PH; Nsango SE; Chesnais CB; Dinglasan RR; de Meeûs T; Morlais I
    Infect Genet Evol; 2016 Nov; 45():138-144. PubMed ID: 27566334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.